Unknown

Dataset Information

0

In vitro Impact of Yeast Expressed Hybrid Peptide CATH-2TP5 as a Prophylactic Measure Toward Sepsis and Inflammation.


ABSTRACT: CATH-2TP5 is a linear cationic hybrid peptide, consequent from naturally occurring antimicrobial peptide (AMPs) Cathelicidin-2 (CATH-2) and Immunomodulatory peptide Thymopentin (TP5) having dynamic and potent anti-inflammatory activities without hemolytic effect. The biocompatible mechanism of CATH-2TP5 is favored to explore new methodologies in the direction of biomedical applications. In this retrospectively study, an antiendotoxin and anti-inflammatory hybrid peptide CATH-2TP5 was emulated into pPICZ?-A and successfully expressed in Pichia pastoris (P. pastoris). The recombinant CATH-2TP5 was purified through the Ni-affinity column and reversed-phase HPLC. The purified CATH-2TP5 peptide exhibited robust anti-endotoxin activity and significantly (p < 0.05) neutralized the effect of lipopolysaccharide (LPS). Furthermore, the down-regulated effect of CATH-2TP was more pronounced (p < 0.05) on LPS-induced cytotoxic effects, nitric oxide secretion and pro-inflammatory cytokines (TNF-?, IL-6, and IL-1?) in murine RAW264.7 macrophages. As associated to control and parental peptide the number of apoptotic cells was also contracted with the treatment of CATH-2TP5. Thus, we concluded that CATH-2TP5 peptide may be used in various biomedical applications as a therapeutic drug.

SUBMITTER: Ahmad B 

PROVIDER: S-EPMC7283555 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>In vitro</i> Impact of Yeast Expressed Hybrid Peptide CATH-2TP5 as a Prophylactic Measure Toward Sepsis and Inflammation.

Ahmad Baseer B   Hanif Quratulain Q   Wei Xubiao X   Zhang Lulu L   Sabir Naveed N   Li Zhongxuan Z   Cheng Junhao J   Khan Shahzad Akbar SA   Basit Abdul A   Shahid Muhammad M   Rehman Amin Ur AU   Si Dayong D   Zhang Rijun R  

Frontiers in bioengineering and biotechnology 20200603


CATH-2TP5 is a linear cationic hybrid peptide, consequent from naturally occurring antimicrobial peptide (AMPs) Cathelicidin-2 (CATH-2) and Immunomodulatory peptide Thymopentin (TP5) having dynamic and potent anti-inflammatory activities without hemolytic effect. The biocompatible mechanism of CATH-2TP5 is favored to explore new methodologies in the direction of biomedical applications. In this retrospectively study, an antiendotoxin and anti-inflammatory hybrid peptide CATH-2TP5 was emulated in  ...[more]

Similar Datasets

| S-EPMC7221121 | biostudies-literature
| S-EPMC1797814 | biostudies-literature
| S-EPMC4510266 | biostudies-literature
2021-07-28 | GSE152452 | GEO
2008-07-15 | GSE9888 | GEO
| S-EPMC3525972 | biostudies-literature
| S-EPMC4153893 | biostudies-literature
| S-EPMC3584648 | biostudies-other
| S-EPMC4346123 | biostudies-literature
| S-EPMC10755722 | biostudies-literature